CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Ampersand – part of Global Digital Health 100
31 Aug 2018
My IBD Care achieves a top score of 85% on the Orcha App Store
09 Jul 2019
My IBD Care, an app for patients with Inflammatory Bowel Disease, has entered the Orcha listings as the highest rated app in its segment.
Press Release: Ampersand Health launches a new digital therapeutic for people living with Inflammatory Arthritis
19 Jan 2021
Ampersand Health, experts in digital therapeutics for long-term inflammatory conditions, announce the launch of My Arthritis DTx to support people living with...
Insight Live: Public Sector
16 Feb 2021
We are attending Insight Live 2021 this coming March.
Press Release: London NHS CCGs Discuss Benefits of Using New HealthSuite App from Ampersand
19 Jul 2018
Clinical Commissioning Groups (CCGs) from across London have expressed interest in trialling and adopting digital self-management platform HealthSuite from...
